CIK 0001570562 · Accelerated filer
Evolus, Inc.
Sign in to watch- Ticker
- EOLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461385614
- Phone
- (949) 284-4555
- Business address
- 520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
- Former names
- Evolus, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $950,019
- in 1 filing
Net −$950,019. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 29 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-08 | MOATAZEDI DAVID See Remarks | Sale | −31,300 | $9.73 | $305K | 603,944 |
| 2023-12-06 | MOATAZEDI DAVID See Remarks | Sale | −51,348 | $10.09 | $518K | 635,244 |
| 2023-10-16 | Medytox Inc. Former 10% Owner | Sale | −1,690,663 | $7.50 | $12.7M | 3,381,326 |
| 2023-09-06 | Beaver Sandra Chief Financial Officer | Sale 10b5-1 | −3,178 | $9.70 | $31K | 113,368 |
| 2023-08-21 | Yamagishi-Dressler Tomoko Chief Marketing Officer | Grant or award | +63,358 | 63,358 | ||
| 2023-08-21 | Yamagishi-Dressler Tomoko Chief Marketing Officer | Grant or award · Stock Option (Right to Buy) | +83,555 | 83,555 | ||
| 2023-08-16 | Avelar Rui See Remarks | Sale 10b5-1 | −2,211 | $10.27 | $23K | 353,386 |
| 2023-08-16 | Beaver Sandra Chief Financial Officer | Sale 10b5-1 | −2,211 | $10.27 | $23K | 116,546 |
| 2023-08-16 | MOATAZEDI DAVID See Remarks | Sale 10b5-1 | −14,778 | $10.27 | $152K | 686,592 |
| 2023-08-15 | Malik Vikram Director | Purchase | +174,967 | $7.41 | $1.3M | 275,550 |
| 2023-08-14 | Avelar Rui See Remarks | Grant or award 10b5-1 | +19,672 | 355,597 | ||
| 2023-08-14 | Beaver Sandra Chief Financial Officer | Grant or award 10b5-1 | +19,672 | 118,757 | ||
| 2023-08-14 | MOATAZEDI DAVID See Remarks | Grant or award 10b5-1 | +91,803 | 701,370 | ||
| 2023-08-11 | Malik Vikram Director | Other acquisition | +22,998 | 100,583 | ||
| 2023-08-11 | BLANK SIMONE Director | Other acquisition | +109 | 63,283 | ||
| 2023-08-11 | BLANK SIMONE Director | Other acquisition | +115,206 | 482,783 | ||
| 2023-08-11 | HAYMAN ROBERT Director | Other acquisition | +218 | 48,392 | ||
| 2023-08-11 | HAYMAN ROBERT Director | Other acquisition | +366 | 10,366 | ||
| 2023-05-08 | MOATAZEDI DAVID See Remarks | Grant or award · Restricted Stock Units | +560,000 | 560,000 | ||
| 2023-03-27 | MOATAZEDI DAVID See Remarks | Sale 10b5-1 | −6,110 | $8.47 | $52K | 609,567 |
Page 7 of 16 · 303 trades